MedTrace Logo

Revascularization StrategIes for ST Elevation Myocardial Infarction Trial

NCT03263468 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3520

Last updated 2017-08-28

No results posted yet for this study

Summary

This study is being conducted in patients with a major heart attack caused by a blocked artery undergoing Percutaneous Coronary Intervention (PCI) to open up the blockage. Up to 50% of people with an heart attack are found to have one or more additional narrowings that did not cause the heart attack. At present the best way to manage these additional blockages is not known. Many cardiologist recommend opening these blockages at at a later time after the heart attack. The present study is examining if PCI of all blockages at the same time as the PCI for the artery that caused the major heart attack (SS-PCI) will reduce the amount of heart damage compared to performing PCI of additional blockages 2-45 days later (IRA-PCI). Clinical follow up will be completed at 3, 12 and 24 months to determine heart function and monitor adverse events.

Conditions

  • ST Elevation Myocardial Infarction
  • Coronary Stenting
  • Primary Angioplasty

Interventions

PROCEDURE

Same sitting PCI with complete revascularization

revascualrization of the non IRA (infarct related artery) of \> 2.0 mm by coronary angioplasty/stenting at the time of primary PCI

PROCEDURE

Staged PCI with complete revsacularization >48 hours pf primary PCI

revascualrization of the non IRA (infarct related artery) of \> 2.0 mm by coronary angioplasty/stenting \>48 hours to 45 days post primary PCI

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Akshay Bagai, MD · Unity Health Toronto

  • Asim Cheema, MD · Unity Health Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2020-12-31
Completion
2021-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03263468 on ClinicalTrials.gov